Tested Applications
| Positive WB detected in | A431 cells, DU 145 cells |
| Positive IHC detected in | human pancreas cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21333-1-AP targets FAM129A in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag15413 Product name: Recombinant human FAM129A protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-350 aa of BC030531 Sequence: MGGSASSQLDEGKCAYIRGKTEAAIKNFSPYYSRQYSVAFCNHVRTEVEQQRDLTSQFLKTKPPLAPGTILYEAELSQFSEDIKKWKERYVVVKNDYAVESYENKEAYQRGAAPKCRILPAGGKVLTSEDEYNLLSDRHFPDPLASSEKENTQPFVVLPKEFPVYLWQPFFRHGYFCFHEAADQKRFSALLSDCVRHLNHDYMKQMTFEAQAFLEAVQFFRQEKGHYGSWEMITGDEIQILSNLVMEELLPTLQTDLLPKMKGKKNDRKRTWLGLLEEAYTLVQHQVSEGLSALKEECRALTKGLEGTIRSDMDQIVNSKNYLIGKIKAMVAQPAEKSCLESVQPFLASI Predict reactive species |
| Full Name | family with sequence similarity 129, member A |
| Calculated Molecular Weight | 928 aa, 103 kDa |
| Observed Molecular Weight | 150 kDa |
| GenBank Accession Number | BC030531 |
| Gene Symbol | FAM129A |
| Gene ID (NCBI) | 116496 |
| RRID | AB_10733106 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9BZQ8 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for FAM129A antibody 21333-1-AP | Download protocol |
| IHC protocol for FAM129A antibody 21333-1-AP | Download protocol |
| WB protocol for FAM129A antibody 21333-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The FAM129A Polyclonal antibody (Cat# 21333-1-AP) has 8 citations published in journals including Int J Oral Sci, J Adv Res, Cell Death Discov, Front Cell Dev Biol, Ren Fail, J Cancer, Mol Biol Rep, and Vasc Med. Research fields span oncology (oral squamous cell carcinoma, hepatocarcinoma, ccRCC, bladder cancer), ER stress and autophagy, osteoclast biology, apoptosis regulation, and vascular endothelial dysfunction in aging and sepsis.
| Species | Application | Title |
|---|---|---|
Int J Oral Sci Phenformin activates ER stress to promote autophagic cell death via NIBAN1 and DDIT4 in oral squamous cell carcinoma independent of AMPK | ||
J Adv Res MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A.
| ||
Cell Death Discov miR-4521-FAM129A axial regulation on ccRCC progression through TIMP-1/MMP2/MMP9 and MDM2/p53/Bcl2/Bax pathways. | ||
Front Cell Dev Biol The Regulatory Role of GBF1 on Osteoclast Activation Through EIF2a Mediated ER Stress and Novel Marker FAM129A Induction. | ||
J Cancer Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer.
|







